PF-Atlas › Mechanisms › Integrin avb6/b1

Integrin avb6/b1 in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

Integrin avb6/b1 is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting Integrin avb6/b1

PLN-74809

Clinical trials

PLN-74809 — INTEGRIS-IPF
Medical disclaimer. This is a research summary, not medical advice.